牛叉诊股

[{"date":"2026.08.11","stock":"4.03","trade":"0.17","ind":"-0.40"},{"date":"2026.08.10","stock":"-0.19","trade":"1.23","ind":"0.04"},{"date":"2026.08.07","stock":"4.48","trade":"4.40","ind":"1.42"},{"date":"2026.08.06","stock":"-0.34","trade":"0.12","ind":"-0.24"},{"date":"2026.08.05","stock":"2.23","trade":"0.50","ind":"1.86"},{"date":"2026.08.04","stock":"2.59","trade":"2.05","ind":"3.25"},{"date":"2026.08.03","stock":"0.05","trade":"0.60","ind":"-0.96"},{"date":"2026.07.31","stock":"3.42","trade":"1.69","ind":"2.21"},{"date":"2026.07.30","stock":"-3.47","trade":"-1.97","ind":"-2.73"},{"date":"2026.07.29","stock":"-0.08","trade":"0.51","ind":"1.10"},{"date":"2026.07.28","stock":"-0.68","trade":"-1.30","ind":"-4.52"},{"date":"2026.07.27","stock":"3.68","trade":"3.35","ind":"2.72"},{"date":"2026.07.24","stock":"-2.87","trade":"-4.36","ind":"-2.47"},{"date":"2026.07.23","stock":"-2.71","trade":"0.60","ind":"0.44"},{"date":"2026.07.22","stock":"0.96","trade":"0.08","ind":"-1.42"},{"date":"2026.07.21","stock":"-1.60","trade":"-1.41","ind":"4.81"},{"date":"2026.07.20","stock":"2.63","trade":"-0.39","ind":"-0.71"},{"date":"2026.07.17","stock":"-13.16","trade":"-7.15","ind":"-5.40"},{"date":"2026.07.16","stock":"-0.76","trade":"0.97","ind":"-1.97"},{"date":"2026.07.15","stock":"6.09","trade":"3.85","ind":"-0.97"},{"date":"2026.07.14","stock":"-1.87","trade":"2.69","ind":"2.77"}]

广生堂,深证成指,化学制药指数

压力支撑

该股压力位为97.80元，支撑位为93.30元。

[{"text":"\u538b\u529b\u4f4d","value":"97.80","date":1786377600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"93.30","date":1786377600,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.5资金面打败了88%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体无进出。

更新时间：08月11日 20:30

机构今日流向(万元)	-29.74	机构5日流向(万元)	61.12
机构10日流向(万元)	-1614.21	机构20日流向(万元)	-8829.98

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加282.55万股，其中基金净减仓4家，主力净增仓35家，请投资者中长期谨慎为宜。

截止2025-12-31，共66家主力机构（基金59家，基本养老保险基金1家，一般法人4家，QFII2家），持仓量总计5155.46万股，占流通A股37.71%
其中，基金持仓与2025-06-30相比：
增仓：5家，增持 3.58万股
减仓：9家，减持 272.58万股
新出现在主力名单中：47家，持有631.21万股
从主力名单中消失：12家，原持有130.94万股

消息面诊股

诊断结果：5.5消息面打败了32%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	公司股东股份解押	2026-07-30
一般消息	股东大会	年度股东大会	2026-04-29
一般消息	分红转增	不分配不转增	2026-04-29
重大利空	业绩预告	预计增亏	2026-01-31
一般消息	高管变动	取消监事会	2025-11-21
一般消息	分红转增	不分配不转增	2025-08-22

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	1条	0条

行业面诊股

诊断结果：4.1行业面打败了33%的股票化学制药行业最新资金流向

近10日来该行业走势明显向上，跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，跑赢大盘。

[{"date":"2026.08.11","price":"-0.40","value":"0.17"},{"date":"2026.08.10","price":"0.04","value":"1.23"},{"date":"2026.08.07","price":"1.42","value":"4.40"},{"date":"2026.08.06","price":"-0.24","value":"0.12"},{"date":"2026.08.05","price":"1.86","value":"0.50"},{"date":"2026.08.04","price":"3.25","value":"2.05"},{"date":"2026.08.03","price":"-0.96","value":"0.60"},{"date":"2026.07.31","price":"2.21","value":"1.69"},{"date":"2026.07.30","price":"-2.73","value":"-1.97"},{"date":"2026.07.29","price":"1.10","value":"0.51"},{"date":"2026.07.28","price":"-4.52","value":"-1.30"},{"date":"2026.07.27","price":"2.72","value":"3.35"},{"date":"2026.07.24","price":"-2.47","value":"-4.36"},{"date":"2026.07.23","price":"0.44","value":"0.60"},{"date":"2026.07.22","price":"-1.42","value":"0.08"},{"date":"2026.07.21","price":"4.81","value":"-1.41"},{"date":"2026.07.20","price":"-0.71","value":"-0.39"},{"date":"2026.07.17","price":"-5.40","value":"-7.15"},{"date":"2026.07.16","price":"-1.97","value":"0.97"},{"date":"2026.07.15","price":"-0.97","value":"3.85"},{"date":"2026.07.14","price":"2.77","value":"2.69"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	哈药股份	102.70%	28.22%	5.9分
2	哈三联	43.36%	17.58%	5.7分
3	博瑞医药	36.23%	14.98%	5.0分
4	海南海药	25.21%	0.00%	4.6分
5	永安药业	23.51%	5.32%	5.4分
6	赛分科技	22.40%	6.63%	6.4分
7	海正药业	19.50%	13.99%	5.8分
8	冀衡医药	18.94%	14.78%	5.7分
9	纳微科技	17.62%	17.46%	6.8分
10	普洛药业	17.34%	1.27%	5.6分
11	石药创新	15.83%	15.93%	6.1分
12	中哲精化	15.73%	9.38%	6.2分
13	誉衡药业	15.46%	18.18%	5.8分
14	ST复华	13.19%	6.46%	4.5分
15	莱美药业	12.24%	4.72%	5.1分
16	罗欣药业	12.10%	3.13%	6.2分
17	百济神州	11.64%	14.64%	6.3分
18	ST天圣	10.83%	5.35%	4.4分
19	向日葵	10.71%	3.33%	4.3分
20	莎普爱思	10.10%	3.35%	5.3分
21	恩华药业	9.63%	2.92%	5.7分
22	翰宇药业	9.61%	21.78%	6.2分
23	海普瑞	9.33%	9.89%	5.6分
24	常山药业	9.19%	6.90%	5.2分
25	广济药业	9.11%	4.71%	5.6分
26	汉商集团	8.75%	5.87%	5.9分
27	亚太药业	8.52%	16.04%	5.0分
28	微芯生物	8.50%	13.95%	5.9分
29	泰恩康	8.49%	4.30%	5.5分
30	天宇股份	7.68%	4.44%	5.6分
31	华海药业	7.48%	7.04%	6.2分
32	ST惠程	7.02%	7.02%	4.9分
33	富士莱	6.73%	4.93%	5.6分
34	富祥股份	6.63%	13.03%	6.0分
35	丰原药业	6.49%	6.68%	6.1分
36	康芝药业	6.43%	3.51%	5.2分
37	东亚药业	6.37%	5.66%	4.7分
38	威尔药业	6.26%	11.27%	5.7分
39	赛托生物	6.01%	4.80%	5.7分
40	新和成	5.56%	0.96%	5.4分
41	拓新药业	5.45%	3.89%	5.0分
42	川宁生物	5.25%	1.69%	4.8分
43	华邦健康	5.14%	0.90%	4.5分
44	德展健康	5.04%	3.81%	4.6分
45	鲁抗医药	5.03%	0.54%	5.1分
46	ST人福	4.97%	2.34%	5.4分
47	健友股份	4.71%	0.98%	5.1分
48	-	4.69%	4.13%	分
49	九典制药	4.52%	1.71%	4.7分
50	仟源医药	4.23%	7.52%	6.1分
51	润都股份	4.08%	5.61%	6.0分
52	华特达因	4.04%	1.21%	5.1分
53	舒泰神	3.94%	7.14%	5.2分
54	华北制药	3.94%	2.87%	5.4分
55	兴齐眼药	3.91%	1.70%	5.5分
56	-	3.90%	4.25%	分
57	本立科技	3.78%	1.88%	5.1分
58	福安药业	3.73%	3.73%	5.5分
59	同和药业	3.69%	2.63%	5.5分
60	神奇制药	3.61%	2.99%	6.2分
61	金城医药	3.48%	5.43%	6.1分
62	易明医药	3.36%	6.44%	5.8分
63	北陆药业	3.27%	6.37%	5.7分
64	迪哲医药	3.11%	15.56%	5.4分
65	海思科	3.10%	14.25%	7.0分
66	海辰药业	3.08%	4.63%	6.1分
67	凯因科技	2.91%	7.08%	5.5分
68	浙江医药	2.88%	2.71%	5.7分
69	海翔药业	2.85%	-1.46%	4.9分
70	复星医药	2.83%	4.92%	5.8分
71	福元医药	2.75%	4.20%	5.7分
72	国邦医药	2.66%	-2.11%	4.9分
73	广生堂	2.65%	10.53%	5.6分
74	百利天恒	2.57%	8.74%	5.1分
75	华仁药业	2.53%	3.65%	5.1分
76	宣泰医药	2.53%	8.37%	5.6分
77	金陵药业	2.51%	2.67%	5.9分
78	山河药辅	2.50%	3.50%	5.5分
79	盟科药业	2.50%	11.51%	5.6分
80	东北制药	2.33%	3.21%	5.5分
81	东诚药业	2.14%	3.49%	5.7分
82	民生健康	2.07%	4.81%	5.8分
83	天新药业	1.79%	-0.91%	4.8分
84	溢多利	1.68%	2.89%	5.5分
85	卫信康	1.44%	4.20%	5.4分
86	昂利康	1.37%	5.67%	5.5分
87	健康元	1.27%	1.96%	5.4分
88	-	1.26%	16.68%	分
89	亿帆医药	0.98%	-0.58%	5.2分
90	石药景峰	0.88%	10.79%	5.1分
91	仙琚制药	0.83%	-1.84%	4.8分
92	海森药业	0.74%	4.70%	5.0分
93	北大医药	0.55%	2.82%	4.9分
94	奥锐特	0.39%	1.53%	5.2分
95	恒瑞医药	0.27%	2.90%	5.4分
96	海创药业	0.10%	15.75%	5.5分
97	上海谊众	0.02%	5.04%	5.4分
98	诚意药业	-0.13%	2.21%	5.6分
99	艾力斯	-0.15%	8.61%	6.1分
100	丽珠集团	-0.16%	-0.23%	5.3分
101	-	-0.21%	1.74%	分
102	通化金马	-0.30%	-5.19%	4.6分
103	键凯科技	-0.30%	18.75%	5.8分
104	复旦张江	-0.38%	6.00%	5.2分
105	华东医药	-0.43%	4.63%	5.7分
106	华润双鹤	-0.61%	0.49%	5.0分
107	金石亚药	-0.68%	13.17%	5.8分
108	悦康药业	-1.03%	7.09%	5.5分
109	西点药业	-1.05%	4.06%	5.4分
110	-	-1.08%	2.76%	分
111	ST诺泰	-1.16%	3.23%	4.9分
112	奥翔药业	-1.68%	4.21%	5.2分
113	信立泰	-2.01%	4.46%	5.7分
114	国药现代	-2.02%	-0.57%	4.6分
115	海欣股份	-2.08%	5.99%	6.0分
116	宏源药业	-2.14%	8.05%	4.9分
117	司太立	-2.17%	1.47%	4.8分
118	小方制药	-2.25%	3.81%	5.4分
119	联环药业	-2.36%	1.05%	5.5分
120	力生制药	-2.38%	1.79%	5.1分
121	尔康制药	-2.40%	3.83%	5.3分
122	贝达药业	-2.41%	17.13%	7.0分
123	辰欣药业	-3.11%	-0.34%	4.6分
124	新华制药	-3.25%	1.01%	5.0分
125	-	-3.29%	5.03%	分
126	京新药业	-3.33%	3.64%	5.6分
127	-	-3.35%	5.41%	分
128	千红制药	-3.42%	-3.28%	4.8分
129	汇宇制药	-3.85%	12.90%	6.0分
130	-	-4.08%	1.51%	分
131	多瑞医药	-4.11%	3.92%	4.3分
132	科伦药业	-4.29%	9.77%	5.7分
133	中关村	-4.77%	2.95%	5.4分
134	吉贝尔	-4.84%	4.16%	5.5分
135	奥赛康	-5.48%	2.60%	5.8分
136	花园生物	-5.48%	16.64%	6.0分
137	-	-6.01%	16.59%	分
138	亨迪药业	-6.41%	7.84%	6.1分
139	共同药业	-6.78%	7.10%	6.1分
140	科源制药	-7.60%	21.67%	5.5分
141	ST能特	-7.79%	-0.88%	4.6分
142	津药药业	-8.35%	8.41%	5.5分
143	圣诺生物	-8.53%	10.42%	6.2分
144	一品红	-8.92%	4.07%	5.4分
145	新天地	-9.20%	3.16%	5.5分
146	首药控股	-9.30%	14.72%	5.1分
147	ST南新	-10.52%	5.19%	4.8分
148	华纳药厂	-10.66%	5.33%	5.4分
149	立方制药	-11.15%	6.27%	5.8分
150	苑东生物	-12.93%	13.09%	5.4分
151	亚虹医药	-14.50%	10.25%	5.0分
152	美诺华	-14.53%	13.06%	5.0分
153	前沿生物	-14.99%	19.06%	5.8分
154	双鹭药业	-15.34%	3.47%	4.8分
155	益方生物	-16.43%	12.15%	4.2分
156	灵康药业	-16.49%	9.57%	5.9分
157	泽璟制药	-18.25%	12.31%	5.5分
158	必贝特	-21.30%	20.63%	5.9分

<上一页 1 2 3 4 5...27 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.0基本面打败了18%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，但多数机构认为该股有长期投资价值。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 145/214 ， 38/214。

[{"date":"2026-03-31","value":"-9.80","vol":"0.45"},{"date":"2025-12-31","value":"-68.32","vol":"-1.85"},{"date":"2025-09-30","value":"-30.03","vol":"1.60"},{"date":"2025-06-30","value":"-20.43","vol":"1.26"},{"date":"2025-03-31","value":"-8.24","vol":"-0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	-9.80	-68.32	-30.03	-20.43	-8.24
行业(%)	0.45	-1.85	1.60	1.26	-0.13

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"66.95","vol":"50.98"},{"date":"2025-12-31","value":"62.32","vol":"49.96"},{"date":"2025-09-30","value":"61.91","vol":"49.79"},{"date":"2025-06-30","value":"61.09","vol":"49.69"},{"date":"2025-03-31","value":"65.63","vol":"49.05"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	66.95	62.32	61.91	61.09	65.63
行业(%)	50.98	49.96	49.79	49.69	49.05

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 71/214 ， 62/214。

[{"date":"2026-03-31","value":"0.85","vol":"24.44"},{"date":"2025-12-31","value":"-5.68","vol":"38.58"},{"date":"2025-09-30","value":"-3.21","vol":"142.64"},{"date":"2025-06-30","value":"-4.27","vol":"79.18"},{"date":"2025-03-31","value":"-18.69","vol":"0.16"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	0.85	-5.68	-3.21	-4.27	-18.69
行业(%)	24.44	38.58	142.64	79.18	0.16

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"9.00","vol":"52.58"},{"date":"2025-12-31","value":"-39.37","vol":"-24.51"},{"date":"2025-09-30","value":"-57.96","vol":"3.72"},{"date":"2025-06-30","value":"-85.05","vol":"66.32"},{"date":"2025-03-31","value":"-94.56","vol":"-9.37"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	9.00	-39.37	-57.96	-85.05	-94.56
行业(%)	52.58	-24.51	3.72	66.32	-9.37

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 102/214 ， 126/214。

[{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.29","vol":"0.41"},{"date":"2025-09-30","value":"0.21","vol":"0.31"},{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.07","vol":"0.10"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.07	0.29	0.21	0.15	0.07
行业(次)	0.10	0.41	0.31	0.21	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.26","vol":"0.64"},{"date":"2025-12-31","value":"1.31","vol":"2.56"},{"date":"2025-09-30","value":"0.93","vol":"1.94"},{"date":"2025-06-30","value":"0.62","vol":"1.30"},{"date":"2025-03-31","value":"0.28","vol":"0.66"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.26	1.31	0.93	0.62	0.28
行业(次)	0.64	2.56	1.94	1.30	0.66

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-20.41","vol":"-2.75"},{"date":"2025-12-31","value":"10.01","vol":"16.48"},{"date":"2025-09-30","value":"-24.06","vol":"4.59"},{"date":"2025-06-30","value":"-6.13","vol":"2.93"},{"date":"2025-03-31","value":"-12.86","vol":"-26.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-20.41	10.01	-24.06	-6.13	-12.86
行业	-2.75	16.48	4.59	2.93	-26.34

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.60","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.30","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	0.60	-	0.30	-
行业	0.00	1.60	0.00	1.72	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 72/214 ， 42/214。

[{"date":"2026-03-31","value":"1.02","vol":"3.58"},{"date":"2025-12-31","value":"1.08","vol":"3.33"},{"date":"2025-09-30","value":"1.03","vol":"3.50"},{"date":"2025-06-30","value":"0.67","vol":"3.68"},{"date":"2025-03-31","value":"0.69","vol":"3.58"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.02	1.08	1.03	0.67	0.69
行业	3.58	3.33	3.50	3.68	3.58

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.61","vol":"2.94"},{"date":"2025-12-31","value":"0.64","vol":"2.71"},{"date":"2025-09-30","value":"0.62","vol":"2.75"},{"date":"2025-06-30","value":"0.30","vol":"2.90"},{"date":"2025-03-31","value":"0.35","vol":"2.81"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	0.61	0.64	0.62	0.30	0.35
行业	2.94	2.71	2.75	2.90	2.81

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 92/214 ， 4/214。

[{"date":"2026-03-31","value":"77.64","vol":"33.40"},{"date":"2025-12-31","value":"75.27","vol":"34.57"},{"date":"2025-09-30","value":"69.18","vol":"34.00"},{"date":"2025-06-30","value":"76.15","vol":"34.11"},{"date":"2025-03-31","value":"73.45","vol":"34.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	77.64	75.27	69.18	76.15	73.45
行业(%)	33.40	34.57	34.00	34.11	34.06

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"4.36","vol":"9.83"},{"date":"2025-12-31","value":"3.80","vol":"1.77"},{"date":"2025-09-30","value":"2.74","vol":"1.19"},{"date":"2025-06-30","value":"3.55","vol":"0.88"},{"date":"2025-03-31","value":"3.06","vol":"1.44"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	4.36	3.80	2.74	3.55	3.06
行业(%)	9.83	1.77	1.19	0.88	1.44

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
中邮证券	2026-05-20	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"-1.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-3.49","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.56","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-2.18","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-0.86","blueLineValue":"-0.54","type":"YC"}]

[广生堂]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]